Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Raloxifene hydrochloride

EU orphan designation number: EU/3/10/730   
Active ingredient: Raloxifene hydrochloride
Indication: Treatment of hereditary haemorrhagic telangiectasia
Sponsor: Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, 28006 Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan designation EMEA/OD/138/09 (2010)3900 of 10/06/2010